Latest Developments in Global Clinical Trial Supplies Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Clinical Trial Supplies Market

  • Healthcare
  • Mar 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In April 2025, DHL Supply Chain announced an expansion of its temperature-controlled logistics network in Southeast Asia to support the growing demand for clinical trial shipments in the region. This initiative aims to enhance the secure and timely delivery of temperature-sensitive investigational drugs
  • In March 2024, Myonex, a leading global clinical trial supply company, announced an agreement to acquire Creapharm Group's clinical and commercial packaging and distribution business, as well as its bioservices. Creapharm is headquartered in Reims, France, with additional sites in France and Georgia, USA.
  • In September  2022, Parexel, a leading global clinical research organization (CRO), announced the opening of a new clinical trial supplies and logistics depot in Suzhou, China. This strategically located facility will provide local and international biopharmaceutical companies conducting clinical trials in the region with timely access to necessary supplies and investigative treatments for distribution to clinical sites and patients worldwide.

Frequently Asked Questions

The market is segmented based on Segmentation, By Services (Storage, Manufacturing, Packaging and Labelling and Distribution), Clinical Phase (Phase III, Phase II, Phase IV, Phase I), Therapeutic Uses (Oncology, Cardiovascular Diseases, Dermatology, Metabolic Disorders, Infectious Diseases, Respiratory Diseases, CNS and Mental Disorders, Blood Disorders and Others), End User (Contract Research Organizations, Pharmaceutical and Biotechnology Companies)- Industry Trends and Forecast to 2032 .
The Global Clinical Trial Supplies Market size was valued at USD 3.82 USD Billion in 2024.
The Global Clinical Trial Supplies Market is projected to grow at a CAGR of 8.4% during the forecast period of 2025 to 2032.
The major players operating in the market include Market players covered: , Movianto , Sharp Services LLC , Thermo Fisher Scientific , Catalent , , PCI Pharma Services , Almac Group , PAREXEL International Corporation , Bionical Emas , Alium Medical Limited , Myonex , Clinigen Limited , Ancillare LP , SIRO Clinpharm Private Limited , Clinigen Clinical Supplies Management , Biocair ,.
The market report covers data from the North America.